- Home
- News
- us virgislands
- disease development
Refine by
Disease Development Articles & Analysis
379 news found
Creative BioMart, a biotechnology company focused on protein-related research solutions, has recently upgraded its epitope mapping service to better support researchers in therapeutic antibody development, vaccine design, and immunogenicity studies. The updated platform integrates multiple experimental approaches with customizable strategies, enabling more accurate identification ...
Several studies have shown that, depending on their properties and origin, extracellular vesicles, such as exosomes, have specific cell tropism and can be used to target diseased tissues or organs. Exosomes are derived from endosomes. These membranous vesicles are released outside the cell by fusing with the plasma membrane via a multivesicular body (MVB). ...
Researchers have long recognized the importance of CCM in regulating cellular function and contributing to the understanding of various diseases, including cancer, diabetes, and neurodegenerative disorders. ...
These models—chemically induced, genetically engineered, or diet-induced—have the potential to advance diabetes research by giving scientists the means to support the identification and development of novel treatment approaches. Diabetes mellitus, a chronic condition characterized by elevated blood sugar levels, affects millions worldwide and poses serious health ...
As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics has announced the launch of its Zika Virus Animal Model services for scientists to understand the complex mechanisms of Zika virus infection and develop effective countermeasures. These models are valuable tools in the research and development of vaccines and ...
Protheragen is proud to release the launch of its comprehensive vaccine development solutions tailored to advance research and development in the field of infectious diseases. ...
Protheragen, a dedicated preclinical research service provider specializing in rare diseases, announces its comprehensive diagnostic development services aimed at empowering researchers in the realm of rare disease research and drug development. ...
Ace Therapeutics is proud to announce the launch of its cardiovascular disease model development services, aiming to empower researchers and pharmaceutical companies with advanced tools and models to accelerate the study of cardiovascular diseases and drug discovery. ...
Regular intake has been demonstrated to reduce symptoms of depression and anxiety, enhance fetal brain development, and lower heart disease risks by managing cholesterol and blood pressure levels. ...
This enhancement aims to offer more precise and comprehensive glycoprotein analysis, catering to the growing demands in the fields of biomedical research, disease biomarker discovery, and therapeutic development. Protein glycosylation, a major post-translational modification, significantly impacts protein folding, stability, and activity. Changes in ...
Following with the announcement of developing small molecule drug for glaucoma, Ace Therapeutics recently unveiled disease model customization services to accelerate further the preclinical research on gastroenterology (GI) and hepatology. ...
The applications of WGS are vast, impacting fields such as disease research, drug discovery, personalized medicine, food safety, agriculture, and pharmacy. ...
Dedicated to the research of new immunotherapeutic vaccines in oncology and prophylactic vaccines for contagious diseases, the aim of the joint Institut Pasteur – Oncovita laboratory is to design and develop vaccine candidates through to proof of concept in humans. ...
ByOncoVITA
As the scientific community continues to explore the intricate world of epigenetics, MeRIP Sequencing emerges as a powerful tool for deciphering the role of RNA modifications in gene expression, development, and disease. CD Genomics' commitment to advancing epigenomics research through state-of-the-art technologies underscores their dedication to driving ...
CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, proudly announces an extensive portfolio of Nervous System Tissue Microarrays designed to support neuroscience research. This comprehensive collection provides researchers with a unique resource to study various neurological conditions and accelerate their investigations into ...
Among these innovations is the development of coated microneedle preparation technology, which has shown promising results in delivering novel drugs to patients. ...
It eliminates the risk of transmitting diseases from animals to humans and provides a consistent and controlled composition. ...
Their use is crucial in unraveling the complexities of related diseases and developing effective treatments. By employing appropriate behavioral research methods, scientists can establish a solid foundation for studying these diseases, leading to invaluable insights and potential breakthroughs in patient care. ...
As several gene therapy approvals for rare disease treatment gain steam in 2023, a comprehensive set of gene therapy development solutions is released to pave richer avenues for rare disease research. ...
Cell-based therapy and tissue engineering have long held the promise of transforming healthcare by enabling the regeneration of damaged tissues and the development of advanced disease models. However, the lack of bioinks suitable for clinical applications has been a significant barrier to progress. ...
ByCELLINK